← Back to Clinical Trials
Recruiting NCT02087852

NCT02087852 Kidney Cancer DNA Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02087852
Status Recruiting
Phase
Sponsor Memorial Sloan Kettering Cancer Center
Condition Renal Cancer
Study Type OBSERVATIONAL
Enrollment 750 participants
Start Date 2014-03
Primary Completion 2027-03

Trial Parameters

Condition Renal Cancer
Sponsor Memorial Sloan Kettering Cancer Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 750
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2014-03
Completion 2027-03
Interventions
salvia for germline DNAthe Kidney Cancer QuestionnaireFamily History Questionnaire (when applicable)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This registry will help us develop better methods of: * Preventing these cancers * Diagnosing these cancers * Treating these cancers

Eligibility Criteria

Inclusion Criteria: Kidney Cancer Case Cohort: * Must be ≥ 18 years of age AND * Must be an English-speaker AND * Must have a diagnosis or suspicion of kidney cancer Family Member Cohort: * Must be ≥ 18 years of age AND * Must be an English-speaker AND * Must be a blood relative of the proband. Family members of probands including mother, father, sisters, brothers, half-sisters, half-brothers, daughters, sons, grandmothers, grandfathers, as well as aunts and uncles are eligible. These individuals need not have kidney cancer, as they will be used for segregation analysis of suspected variants found in the proband; requesting DNA from relatives is required. Control Cohort: * Must be ≥ 18 years of age AND * Must be an English-speaker AND * Must not have a personal history of cancer, with the exception of nonmelanoma skin cancer, AND * Must not be a blood relative of any cases or controls enrolled in this study Exclusion Criteria: * Patients who, in the opinion of the primary MSKCC clinici

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology